Loibl, S., Martin, M., Bonnefoi, H., Untch, M., Kim, S. -., Bear, H. D., . . . Marmé, F. (2025). Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2-breast cancer and residual disease after neoadjuvant chemotherapy: Brief trial updates. Annals of oncology, 36(7), . https://doi.org/10.1016/j.annonc.2025.03.010
Chicago-Zitierstil (17. Ausg.)Loibl, Sibylle, et al. "Final Survival Results from the PENELOPE-B Trial Investigating Palbociclib Versus Placebo for Patients with High-risk HR+/HER2-breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: Brief Trial Updates." Annals of Oncology 36, no. 7 (2025). https://doi.org/10.1016/j.annonc.2025.03.010.
MLA-Zitierstil (9. Ausg.)Loibl, Sibylle, et al. "Final Survival Results from the PENELOPE-B Trial Investigating Palbociclib Versus Placebo for Patients with High-risk HR+/HER2-breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: Brief Trial Updates." Annals of Oncology, vol. 36, no. 7, 2025, https://doi.org/10.1016/j.annonc.2025.03.010.